These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
170 related items for PubMed ID: 1615792
1. Flecainide single oral dose for management of paroxysmal supraventricular tachycardia in children and young adults. Musto B, Cavallaro C, Musto A, D'Onofrio A, Belli A, De Vincentis L. Am Heart J; 1992 Jul; 124(1):110-5. PubMed ID: 1615792 [Abstract] [Full Text] [Related]
2. Electrophysiologic effects and therapeutic efficacy of intravenous flecainide for termination of paroxysmal supraventricular tachycardia. Gambhir DS, Bhargava M, Arora R, Khalilullah M. Indian Heart J; 1995 Jul; 47(3):237-43. PubMed ID: 7558090 [Abstract] [Full Text] [Related]
3. Electrophysiologic and clinical effects of flecainide for recurrent paroxysmal supraventricular tachycardia. Hoff PI, Tronstad A, Oie B, Ohm OJ. Am J Cardiol; 1988 Sep 15; 62(9):585-9. PubMed ID: 3137798 [Abstract] [Full Text] [Related]
4. [Electrophysiological effects and clinical efficacy of flecainide in childhood patients with supraventricular reciprocating paroxysmal tachycardia]. Musto B, D'Onofrio A, Cavallaro C, Musto A, Della Gatta O, Marsico F. G Ital Cardiol; 1987 May 15; 17(5):444-9. PubMed ID: 3115857 [Abstract] [Full Text] [Related]
5. Electrophysiologic effects and clinical efficacy of flecainide in children with recurrent paroxysmal supraventricular tachycardia. Musto B, D'Onofrio A, Cavallaro C, Musto A, Greco R. Am J Cardiol; 1988 Aug 01; 62(4):229-33. PubMed ID: 3135739 [Abstract] [Full Text] [Related]
6. Long-term efficacy and safety of flecainide for supraventricular tachycardia. Neuss H, Schlepper M. Am J Cardiol; 1988 Aug 25; 62(6):56D-61D. PubMed ID: 3136637 [Abstract] [Full Text] [Related]
7. Long-term follow-up of patients with inducible supraventricular tachycardia treated with flecainide or propafenone: therapy guided by transesophageal electropharmacologic testing. Furlanello F, Guarnerio M, Inama G, Vergara G, Del Greco M, Bertoldi A, Dallago M. Am J Cardiol; 1992 Aug 20; 70(5):19A-25A. PubMed ID: 1509994 [Abstract] [Full Text] [Related]
8. Flecainide acetate prevents recurrence of symptomatic paroxysmal supraventricular tachycardia. The Flecainide Supraventricular Tachycardia Study Group. Henthorn RW, Waldo AL, Anderson JL, Gilbert EM, Alpert BL, Bhandari AK, Hawkinson RW, Pritchett EL. Circulation; 1991 Jan 20; 83(1):119-25. PubMed ID: 1898640 [Abstract] [Full Text] [Related]
9. Observations on induction and termination of paroxysmal supraventricular tachycardia by external pacing. Grubb BP, Markel ML, Artman SE, Post WR, Luck JC. Pacing Clin Electrophysiol; 1992 Nov 20; 15(11 Pt 2):1944-52. PubMed ID: 1279577 [Abstract] [Full Text] [Related]
10. Flecainide acetate for treatment of bypass tract mediated reentrant tachycardia. Zee-Cheng CS, Kim SS, Ruffy R. Am J Cardiol; 1988 Aug 25; 62(6):23D-28D. PubMed ID: 3136631 [Abstract] [Full Text] [Related]
11. Treatment of paroxysmal reentrant supraventricular tachycardia with flecainide acetate. Kim SS, Lal R, Ruffy R. Am J Cardiol; 1986 Jul 01; 58(1):80-5. PubMed ID: 3728336 [Abstract] [Full Text] [Related]
12. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group. Hopson JR, Buxton AE, Rinkenberger RL, Nademanee K, Heilman JM, Kienzle MG. Am J Cardiol; 1996 Jan 25; 77(3):72A-82A. PubMed ID: 8607395 [Abstract] [Full Text] [Related]
13. Electrophysiologic effects of isoproterenol in patients with atrioventricular reentrant tachycardia treated with flecainide. Helmy I, Scheinman MM, Herre JM, Sharkey H, Griffin JC. J Am Coll Cardiol; 1990 Dec 25; 16(7):1649-55. PubMed ID: 2123908 [Abstract] [Full Text] [Related]
14. A randomized comparison of flecainide versus verapamil in paroxysmal supraventricular tachycardia. The Flecainide Multicenter Investigators Group. Dorian P, Naccarelli GV, Coumel P, Hohnloser SH, Maser MJ. Am J Cardiol; 1996 Jan 25; 77(3):89A-95A. PubMed ID: 8607397 [Abstract] [Full Text] [Related]
15. Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: a transtelephonic monitoring study. The Flecainide Supraventricular Tachycardia Study Group. Bhandari AK, Anderson JL, Gilbert EM, Alpert BL, Henthorn RW, Waldo AL, Cullen MT, Hawkinson RW, Pritchett EL. Am Heart J; 1992 Aug 25; 124(2):381-6. PubMed ID: 1636582 [Abstract] [Full Text] [Related]
16. Opposite effects of propafenone and flecainide in a patient with reciprocating supraventricular tachycardia. Montenero AS, Natale A, di Bona G, Calvi V, Santarelli P, Manzoli U. Cardiologia; 1990 Mar 25; 35(3):253-6. PubMed ID: 2123130 [Abstract] [Full Text] [Related]
17. Efficacy and safety of long-term oral flecainide acetate in patients with responsive supraventricular tachycardia. Hellestrand KJ. Am J Cardiol; 1996 Jan 25; 77(3):83A-88A. PubMed ID: 8607396 [Abstract] [Full Text] [Related]
18. [Treatment of recurrent supraventricular tachyarrhythmias with flecainide or a flecainide and amiodarone combination]. Purcaro A, Capestro F, Ciampani N, Fratadocchi GB, Mazzanti M, Costantini C, Molini E. G Ital Cardiol; 1987 Aug 25; 17(8):690-8. PubMed ID: 3121426 [Abstract] [Full Text] [Related]
19. Cardiac electrophysiologic effects of flecainide acetate for paroxysmal reentrant junctional tachycardias. Hellestrand KJ, Nathan AW, Bexton RS, Spurrell RA, Camm AJ. Am J Cardiol; 1983 Mar 01; 51(5):770-6. PubMed ID: 6829436 [Abstract] [Full Text] [Related]
20. Safety and efficacy of oral flecainide therapy in patients with atrioventricular re-entrant tachycardia. Cockrell JL, Scheinman MM, Titus C, Helmy I, Langberg JJ, Lee MA, Griffin JC. Ann Intern Med; 1991 Feb 01; 114(3):189-94. PubMed ID: 1898629 [Abstract] [Full Text] [Related] Page: [Next] [New Search]